We source our pipeline and marketed products exclusively through business development transactions and licensing agreements.

Our team has extensive experience in oncology product development and commercialization in the North America, Europe and China.

Specifically, we are looking for:

  • Marketed oncology therapeutics and supportive care products
  • Innovative, patented oncology therapeutics currently in mid- or late-stage clinical trials
  • Targeted therapies that enable selection of patients who are most likely to benefit
  • Early-stage product candidates that may offer benefits over current products or competing product candidates
  • Therapies that address solid and/or liquid tumors, including small molecules, antibodies and protein therapeutics
  • Targets that have demonstrated proof of concept and molecules with defined mechanisms of action

We are also interested in:

  • Potential opportunities to out-license our products for distribution in geographies outside our areas of focus

We are currently not pursuing opportunities in medical devices, off-patent or generic products, stem cell therapies or cell-based products.